miR-452 promotes the development of gastric cancer via targeting EPB41L3
In this study, we found that miR-452 was highly expressed in both tumor tissue and gastric cancer cells, and could directly target the cancer suppressor gene EPB41L3 3′-UTR. miR-452 significantly promoted the proliferation, migration and the S-phase arrest of gastric cancer cells, but EPB41L3 as a downstream target gene of miR-452 reversed such promoting effect. While down-regulation of miR-452 expression significantly inhibited the malignant biological behavior of gastric cancer cells, but this inhibitory effect was reversed by EPB41L3 siRNA. In addition, miR-452 in the gastric cancer xenograft model in nude mice could down-regulated the expression level of EPB41L3 and promote the growth of transplanted tumor in nude mice. Taken together, this study reveals the role of miR-452 in gastric cancer via inhibiting the target gene EPB41L3, suggesting that miR-452 has the potential to become a new target for the diagnosis and treatment of gastric cancer.
Source: Pathology Research and Practice - Category: Pathology Source Type: research
More News: Brain Tumor | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Clear Cell Carcinoma | Colorectal Cancer | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Genetics | Glioma | Hepatocellular Carcinoma | Liver | Liver Cancer | Molecular Biology | Pathology | Prostate Cancer | Study | Transplants | Urology & Nephrology